UPDATE : Wednesday, July 15, 2020
HanAll’s profit increases despite sales drop in Q1
HanAll Biopharma said that it has posted 22.1 billion won ($18.1 million) i...
by Lee Han-soo  |  2020-05-11 18:37
JW CreaGene wins European nod for new bio-drug
JW CreaGene, a subsidiary of JW Shinyak, said Friday that it has won approv...
by Shim Hyun-tai  |  2020-05-08 17:41
Bridge Biotherapeutics scores regulatory nod for trial of NSCLC treatment
Bridge Biotherapeutics said that the Ministry of Food and Drug Safety has g...
by Lee Han-soo  |  2020-05-08 15:45
Celltrion Healthcare launches Remsima SC in Netherlands
Celltrion Healthcare said that it launched Remsima SC, an autoimmune biosim...
by Lee Han-soo  |  2020-05-07 14:53
Cellivery sure to win licensing deal with top pharma company
“A global pharmaceutical company is conducting a verification test on thera...
by Jeong Sae-im  |  2020-05-07 11:27
Theragen Bio starts as independent company
Theragen Bio, a spin-off firm of Theragen Etex, officially launched on Mond...
by Shim Hyun-tai  |  2020-05-06 17:24
Kolon begins testing gene therapy for neuropathic pain in US
Kolon Life Science said Monday it has started the administration of an expe...
by Jeong Sae-im  |  2020-04-27 16:18
Pharmicell’s sales to rise with commercial supply of mPEG
Pharmicell said Friday that it has made the first shipments according to th...
by Shim Hyun-tai  |  2020-04-24 18:10
Herzuma wins 40% of market share in Japan
Celltrion HealthCare said Monday that its biosimilar Herzuma (Ingredient: t...
by Shim Hyun-tai  |  2020-04-21 16:42
‘Stem cell therapy more effective on Covid-19’
“I don’t know why people pay attention only to vaccines and treatments agai...
by Jeong Sae-im  |  2020-04-21 11:01
‘Natural Killer cells predict immunotherapy’s efficacy in lung cancer patients’
Local researchers said the number of natural killer cells and their high ac...
by Jeong Sae-im  |  2020-04-17 16:07
Samsung Bioepis launches anticancer biosimilar in US
Samsung Bioepis said Thursday that it has launched Ontruzant (Ingredient: t...
by Shim Hyun-tai  |  2020-04-16 17:32
What are the odds for successful Invossa trials in US?
Pharmaceutical industry observers are closely following whether Kolon Life ...
by Jeong Sae-im  |  2020-04-14 15:01
Celltrion gets antibody candidates neutralizing new coronavirus
Celltrion said Monday that it has succeeded in securing the final antibody ...
by Shim Hyun-tai  |  2020-04-13 18:16
FDA OKs resumption of phase-3 Invossa trial in US
Kolon Life Science said the U.S. Food and Drug Administration has allowed t...
by Jeong Sae-im  |  2020-04-13 11:58
Samsung signs contract with Vir to make COVID-19 treatment
Samsung Biologics said Friday that it has signed a letter of intent with Vi...
by Shim Hyun-tai  |  2020-04-10 18:07
No Korean firms have entered trials to test COVID-19 drug candidates
Korean pharmaceutical and biotech companies have jumped in developing treat...
by Jeong Sae-im  |  2020-04-08 16:15
Samsung Biologics signs CDO contract with PharmAbcine
Samsung Biologics said Monday that it has signed a contract developing orga...
by Shim Hyun-tai  |  2020-04-06 18:00
AbClon draws many new human antibodies to fight COVID-19
AbClon, a company specializing in developing antibodies, said Monday that i...
by Shim Hyun-tai  |  2020-03-30 17:47
ImmuneMed under fire for inflating drug’s effect against COVID-19
ImmuneMed, a local biotech firm, has come under criticism for exaggerating ...
by Jeong Sae-im  |  2020-03-27 11:49
Back to Top